medigraphic.com
ISSN 1684-1824 (Electronic)

2014, Number 1

<< Back Next >>

Rev Méd Electrón 2014; 36 (1)

Infection by Acinetobacter spp. in the University Hospital

Arnold RM

Language: Spanish
References: 21
Page: 3-14
PDF size: 235.73 Kb.


ABSTRACT

Infections associated to the sanitary care are serious public health problems at the international level because of their frequency and high mortality. In the last ten years, Acinetobacter spp. has emerged as an important nosocomial opportunistic pathogen. Among these species, A. baumanii (B Ab) is the main isolated species covering as many as 92 % of the nosocomial bacteremias. Most of the reports of nosocomial bacteremias by A. baumanii (B Ab) are outbreaks in adult patient intensive care units. It has been reported a boost of this germ antimicrobial resistance. We carried out a cross sectional, descriptive, observational study on Acinetobacter spp. infection, in the University Hospital “Comandante Faustino Pérez Hernández” of Matanzas municipality, from October 2011 to July 2012. Taking into account the absence of a previous study in Matanzas on infections caused by this microorganism, we decided identifying the Acinetobacter spp. incidence according to biological samples and coming-from service and identifying its sensibility/resistance, allowing the instauration of the efficacious treatment of the patients who carry this bacterium, considering the susceptibility pattern found in the study. The most frequently found species was A. baumanii, mainly in endotracheal secretions and hemo-cultures, most of them coming from Intensive Therapy Units, being this service the one contributing with more quantity of multidrug resistant stocks. We found a bigger sensibility to antimicrobials that are not considered first line ones like doxycycline, tetracycline and trimetoprim- ulfametoxazole.


REFERENCES

  1. Hart Casares M, Espinosa Rivera FI, Halley Posada MC. Resistencia a antibióticos en cepas de Acinetobacter baumannii aisladas de enero a marzo del 2010 en el Hospital Clínico quirúrgico "Hermanos Ameijeiras". Rev Cubana Medicina [Internet]. 2010[citado 16 Jun 2012];49(3). Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232010000300001&lng=es&nrm=iso&tlng=es.

  2. Hernández Torres A, García Vázquez E, Yague G, Gomez Gomez J. Acinetobacter baumanii multiresistente. Situación clínica actual y nuevas perspectivas. Rev Española Quimioter [Internet] 2010[citado 16 Jun 2012];23(1):12-9. Disponible en:http://www.seq.es/index2.php?option=com_content&task =view&id=383&pop=1&page=0&Itemid=1.

  3. Vila J, Marco F. Lectura interpretada del antibiograma de bacilos gram negativos no fermentadores. Enferm Infec Microbiol Clin. 2010;28(10):726-36. Citado en PubMed; PMID: 20579775.

  4. Navarro F, Calvo J, Cantón R, Fernández-Cuenca F, Mirelis B. Detección fenotípica de mecanismos de resistencia en microorganismos gramnegativos. Enferm Infecc Microbiol Clin. 2011;29(7):524-34. Citado en PubMed; PMID: 21696863.

  5. Lee K, Yong D, Hoon JS, Chong Y. Multidrug-Resistan Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens. Yonsei Med J. 2011;52(6):879-91. Citado en PubMed; PMID: 22028150.

  6. Peleg A, Seifert H, Paterson DL. Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin Microbiol Rev. 2008;21(3):538-82. Citado en PubMed; PMID: 18625687.

  7. Cisneros JM, Pachón G. Acinetobacter baumannii: un patógeno nosocomial de difícil control. Enferm Infecc Microbiol Clin. 2003;21(5):221-3. Citado en PubMed; PMID: 12732110.

  8. Alvarez-Lerma F, Palomar M, Insausti J, Olaechea P, Cerdá E, Castillo F, et al. Infecciones por Acinetobacter spp. en pacientes críticos en UCI. Enferm Infecc Microbiol Clin. 2005;23(9):533-9. Citado en PubMed; PMID: 16324565.

  9. Akbari M, Niakan M, Taherikalani M, Feizabadi MM, Azadi NA, Soroush S, et al. Rapid identification of Iranian Acinetobacter baumanni strains by single PCR assay using BLAoxa-51–like carbapenemase and evaluation of the antimicrobial resistance profiles of the isolates. Acta Microbiol Inmunol Hung. 2010;57(2): 87-94. Citado en PUbMed; PMID: 20587382.

  10. Hart Casares M, Llanes Rodríguez N, Espinosa Rivera F, Halley Posada MC, Martínez Batista ML, López Suárez AL. Estudio de la sensibilidad antimicrobiana de la especie Acinetobacter baumanii en el Hospital "Hermanos Ameijeiras" 2006. Rev Cubana de Med [Internet]. 2008[citado 16 Jun 2012];47(3). Disponible en: http://www.scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232008000300007&lng=es&nrm=iso&tlng=es

  11. RakaI L, KalencI S, Bošnjak Z, Budimir A, Šijak D, Mulliqi-OsmaniI G. Molecular epidemiology of Acinetobacter baumannii in central intensive care unit in Kosova teaching hospital. Braz J Infect Dis. 2009;13 (6):408-13. Citado en PubMed; PMID: 20464330.

  12. Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro surveillance. 2008;13(47). pii: 19045. Citado en PubMed; PMID: 19021957.

  13. Mezzatesta ML, Trovato G, Gona F, Nicolosi VM, Nicolosi D, Carattoli A, et al. In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy. Ann Clin Microbiol Antimicrob. 2008;7(4). Citado en PubMed; PMID: 18261233.

  14. Eser OK, Ergin A, Hascelik G. Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients. Mikrobiyol Bul. 2009;43(3):383-90. Citado en PubMed; PMID: 19795613.

  15. Taneja N, Singh G, Singh M, Sharma M. Emergence of tigecycline & colistin resistant Acinetobacter baumannii in pacients with complicated urinary tract infections in north India. Indian J Med Res. 2011;133: 681-4.Citado en PubMed; PMID: 21727671.

  16. Lin YC, Hsia KC, Chen YC, Sheng WH, Chang SC, Liao MH, et al. Genetic Bacis of Multidrug Resistance in Acinetobacter Clinical Isolates in Taiwan. Antimocrob Agents Chemother. 2010;54(5):2078-84. Citado en PubMed; PMID: 20194701.

  17. Rahbar M, Mehrgan H, Haji AH. Prevalencia of antibiotic-resistant Acinetobacter baumannii in a 1000-bed tertiary care hospital in Tehran, Iran. Indian J Pathol Microbiol. 2010;53(2):290-3. Citado en PUbMed; PMID: 20551535.

  18. Thapa B, Tribuddharat C, Rugdeekha S, Techachaiwiwat W, Srifuengfung S, Dhiraputra C.Rifampin resistance in carbapenem-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand. Nepal Med Coll J 2009;11(4):232-7. Citado en PubMed; PMID: 20635600.

  19. Adams-Haduch JM, Paterson DL, Sidjabat HE, Pasculle AW, Potoski Brian A, Muto CA, et al. Genetic Basic of Multidrug Resistance in Acinetobacter baumannii Clinical isolates at a Tertiary Medical Center in Pennsylvania. Antimicrobial Agents Chemother. 2008;52(11): 3837-43. Citado en PubMed; PMID: 18725452.

  20. Dizbay M, Altuncekic A, Sezer BE, Ozdemir K, Arman D. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia. Int J Antimicrob Agents. 2008;32(1):29-32. Citado en PubMed; PMID: 18539006.

  21. Al-Swerih NA, Al-Hubail MA, Rotimi Vo. Emergence of tigecycline and colistina resistence in acinetobacter species isolated from patients in Kuwait hospitals. J Chemother. 2011;23(1):13-6. Citado en PubMed; PMID: 21482488.




2020     |     www.medigraphic.com